Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in metastatic colorectal cancer
NCT00044343Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2002
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lapatinib in metastatic colorectal cancer (mCRC), sponsored by GSK. Started Sep 2002; status: completed.
02
Drugs
lapatinib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00044343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044343.